Skip to main content
Advertisement
  • Loading metrics

Correction: Trypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental Model

  • The PLOS Neglected Tropical Diseases Staff

There are errors in the affiliations. The complete, correct affiliations are as follows:

Frédéric-Antoine Dauchy1,2,3, Mélanie Bonhivers4,5, Nicolas Landrein4,5, Denis Dacheux4,5,6, Pierrette Courtois1,2, Florian Lauruol1,2, Sylvie Daulouède1,2, Philippe Vincendeau1,2,7, Derrick R. Robinson4,5

1 University of Bordeaux, UMR IRD CIRAD INTERTRYP 177, laboratoire de parasitologie, F-33000 Bordeaux, France.

2 IRD-CIRAD-University of Bordeaux, UMR INTERTRYP 177, F-34394 Montpellier, France.

3 University Hospital of Bordeaux, Department of infectious and tropical diseases, Hôpital Pellegrin, F-33076 Bordeaux, France.

4 University of Bordeaux, Microbiologie Fondamentale et Pathogénicité, UMR 5234, F-33000 Bordeaux, France.

5 CNRS, Microbiologie Fondamentale et Pathogénicité, UMR 5234, F-33000 Bordeaux, France.

6 Bordeaux INP, ENSTBB, Microbiologie Fondamentale et Pathogénicité, UMR 5234, F-33000 Bordeaux, France.

7 University Hospital of Bordeaux, laboratoire de parasitologie, Hôpital Pellegrin, F-33076 Bordeaux, France.

Reference

  1. 1. Dauchy F-A, Bonhivers M, Landrein N, Dacheux D, Courtois P, Lauruol F, et al. (2016) Trypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental Model. PLoS Negl Trop Dis 10(11): e0005125. pmid:27855164